|
|
|
B6035-10
|
| ApexBio |
|
10 mg |
|
Description: 2-NBDG is a fluorescence-labeled 2-deoxy-glucose analog useful as a tracer for evaluation of cellular glucose metabolism. Glucose is a necessary source of energy for sustaining cell activities and homeostasis in tissues.
|
|
|
|
|
|
B6035-5
|
| ApexBio |
|
5 mg |
|
Description: 2-NBDG is a fluorescence-labeled 2-deoxy-glucose analog useful as a tracer for evaluation of cellular glucose metabolism. Glucose is a necessary source of energy for sustaining cell activities and homeostasis in tissues.
|
|
|
|
|
|
HY-116215
|
| MedChemExpress |
|
10mg |
|
|
|
|
|
|
|
)
|
|
|
|
|
23500
|
| AAT Bioquest |
|
200 Tests |
|
Amino)-2-Deoxyglucose] *CAS#: 186689-07-6*)
|
|
|
|
|
|
|
PROTP60568-2
|
| BosterBio |
|
Regular: 10ug |
|
Description: Interleukin-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 133 amino acids fragment (21-153) having a molecular weight of 20kDa and fused with a 4.5kDa amino-terminal hexahistidine tag. _x000D_ The IL-2 His is purified by proprietary chromatographic techniques._x000D_
|
|
|
|
|
PROTP12643-2
|
| BosterBio |
|
Regular: 20ug |
|
Description: Bone Morphogenetic Protein-2 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated, Polypeptide chain containing 115 amino acids (283-396) and having a molecular mass of 13009 Dalton. ;The BMP-2 is purified by proprietary chromatographic techniques.
|
|
|
|
|
|
|
A00010-2
|
| BosterBio |
|
100ug/vial |
|
|
|
|
A00040-2
|
| BosterBio |
|
100ug/vial |
|
|
|
|
A00370-2
|
| BosterBio |
|
100ug/vial |
|
|
|
|
A03922-2
|
| BosterBio |
|
100ug/vial |
|
|
|
|
A07840-2
|
| BosterBio |
|
100ug/vial |
|
|
|
|
K2021010-2
|
| Biochain |
|
6 ml |
|
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.
|
|
|
|
|
PROTO15263-2
|
| BosterBio |
|
20ug |
|
Description: Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system. The α-defensins are distinguished from the β-defensins by the pairing of their three disulfide bonds. To date, six human β-defensins have been identified; BD-1, BD-2, BD-3, BD-4, BD-5 and BD-6. β-defensins are expressed on some leukocytes and at epithelial surfaces. In addition to their direct antimicrobial activities, they can act as chemoattractants towards immature dendritic cells and memory T cells. The β-defensin proteins are expressed as the C-terminal portion of precursors and are released by proteolytic cleavage of a signal sequence and in some cases, a propeptide sequence. β-defensins contain a six-cysteine motif that forms three intra-molecular disulfide bonds. Recombinant human BD-2 is a 4.3 kDa protein containing 41 amino acid residues.
|
|
|
|
|
PROTP04090-2
|
| BosterBio |
|
25ug |
|
Description: Relaxin-2 is a peptide hormone structurally related to insulin, which is expressed in the placenta, decidua, prostate, and in the ovary during pregnancy. Of the three known relaxin genes, Relaxin-2 is the only relaxin known to circulate in the blood. Relaxin-2 binds specifically to the LGR7 and LGR8 receptors, previously identified as an “orphan” G protein coupled receptors. Signaling by Relaxin-2 through its target receptors enhances the growth of pubic ligaments and ripening of the cervix during birth. Recombinant Relaxin-2 is a nonglycosylated 6.0 kDa disulfide linked heterodimeric protein consisting of a 24 amino acid A-chain and a 29 amino acid B-chain.
|
|
|
|
|
PROTP04351-2
|
| BosterBio |
|
20ug |
|
Description: IL-2 is a powerful immunoregulatory lymphokine produced by T-cells in response to antigenic or mitogenic stimulation. IL-2/IL-2R signaling is required for T-cell proliferation and other fundamental functions which are essential for the immune response. IL-2 stimulates growth and differentiation of B-cells, NK cells, lymphokine activated killer cells, monocytes, macrophages and oligodendrocytes. Recombinant murine IL-2 is a 17.2 kDa protein, containing 149 amino acid residues.
|
|
|
|
|
PROTP05120-2
|
| BosterBio |
|
10ug |
|
Description: PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The glycosylated and unglycosylated forms of PAI-2 are equally effective as inhibitors of urokinase-type plasminogen activator (uPA), the only established physiological target of this serpin. PAI-2 has a unique ability to form dormant polymers spontaneously and reversibly under physiological conditions. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/ml), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein.
|
|
|
|
|
PROTP08253-2
|
| BosterBio |
|
10ug |
|
Description: Matrix metalloproteinases (MMPs) are a family of endoproteases that require zinc and calcium for expressing catalytic activity. These enzymes play a central role in the maintenance and remodeling of the extracellular matrix. Elevated expression of their activity, caused either by up-regulation of their expression or down-regulation of their cognate inhibitors, has been implicated in various degenerative disorders, including arthritis, cardiovascular disease, skeletal growth-plate disorders, and cancer metastasis. MMP-2 is a secreted collagenase with specificity toward Type IV, V, VII, and X collagens. Recombinant human MMP-2 is a 62.0 kDa protein containing the entire catalytic N-terminal domain and the C-terminal domain (552 amino acids).
|
|
|
|
|
PVTBAV03691-2
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVTBAV05689-2
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVTBAV08732-2
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVTBAV11741-2
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVTBAV12881-2
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVTBAV13661-2
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVTBAV20583-2
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVTBAV21973-2
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVTBAV22921-2
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVTBAV26238-2
|
| Lifescience Market |
|
2 ug |
|
|
|
|
R00121-2
|
| BosterBio |
|
5ug/vial |
|
Description: FGF basic (FGF2) is a multipotential fibroblast growth factor that stimulates and supports proliferation, migration and differentiation. Mouse FGF basic (FGF-2) Recombinant Protein is purified FGF basic (FGF-2) produced in yeast.
|
|
|
|
|
R00387-2
|
| BosterBio |
|
5ug/vial |
|
Description: Interleukin-2 (IL-2) is a cytokine produced by T-helper cells in response to antigenic or mitogenic stimulation. It is required for T-cell proliferation and other activities crucial to the regulation of the immune response. Chicken IL-2 Recombinant Protein is purified interleukin-2 produced in yeast.
|
|
|
|
|
PROTQ03403-2
|
| BosterBio |
|
20ug |
|
Description: The Trefoil Factor peptides (TFF1, TFF2 and TFF3) are expressed in the gastrointestinal tract, and appear to play an important role in intestinal mucosal defense and repair. TFF2 has been shown to inhibit gastrointestinal motility and gastric acid secretion. Recent data suggests a potential role for TFF2 in acute and chronic asthma (Nikolaidis, N.M. et al. Am. Journal Respir. Cell Mol. Biol. (2003) 4: 458-464). Recombinant human TFF2 is a 12.0 kDa polypeptide of 107 amino acid residues, which includes a 40-amino acid trefoil motif containing three conserved intramolecular disulfide bonds.
|
|
|
|
|
A00084-2
|
| BosterBio |
|
100ug/vial |
|
|
|
|
A00456-2
|
| BosterBio |
|
100ug/vial |
|
|
|
|
A00901-2
|
| BosterBio |
|
100ug/vial |
|
 Antibody)
|
|
|
A02218-2
|
| BosterBio |
|
200ug |
|
Description: Goat Polyclonal Adiponectin Receptor 2 (mouse) Antibody. Validated in IF, IHC and tested in Mouse.
|
|
|
|
|
A02922-2
|
| BosterBio |
|
100ug/vial |
|
 Antibody)
|
|
|
A07956-2
|
| BosterBio |
|
100ul |
|
Description: Rabbit Polyclonal p56Dok-2 (Ab-299) Antibody. Validated in IF, IHC, WB and tested in Human.
|
|
|
|
|
|
|
|
|
|
|
PROTP04626-2
|
| BosterBio |
|
Regular: 20ug |
|
Description: ErbB-2 Human Recombinant is a 43.4 kDa protein containing 397 amino acid residues of the human Herstatin, and an extra Methionine at N-Terminal (underlined), produced in E.coli.
|
|
|
|
|
M00040-2
|
| BosterBio |
|
100ug/vial |
|
Description: Rabbit Monoclonal Bcl-2 Antibody. Validated in IF, WB and tested in Human, Mouse.
|
|
|
|
|
PA1129-2
|
| BosterBio |
|
100ug/vial |
|
|
|
|
|
|
|
|
|
|
2-82102
|
| CHI Scientific |
|
1 Kit |
|
|
|
|
2-82597
|
| CHI Scientific |
|
1 Kit |
|
|
|
|
2-96123
|
| CHI Scientific |
|
1 Kit |
|
|
|
|
PROTP09104-2
|
| BosterBio |
|
Regular: 20ug |
|
Description: Human Neurone Specific Enolase produced in Human CNS having a molecular mass of 45kDa.
|
|
)
|
|
|
M00456-2
|
| BosterBio |
|
100ug/vial |
|
|
|
|
|
)
|
|
|
ABPEP-20A-2
|
| Alpha Diagnostics |
|
1 |
|
|
|
|
B8158-.2
|
| ApexBio |
|
200 µl (5 mM) |
|
|
|
|
A02215-2
|
| BosterBio |
|
100ug/vial |
|
|
|
|
|
|
M00084-2
|
| BosterBio |
|
100uL |
|
Description: Anti-COX-2 Rabbit Monoclonal Antibody, Clone#RM348 tested in WB, IHC, reactive to Human
|
|
 Protein)
|
|
|
PROTP61812-2
|
| BosterBio |
|
10ug |
Description: The three mammalian isoforms of TGF-β, TGF-β1, β2, β3, signal through the same receptor and elicit similar biological responses. They are multifunctional cytokines that regulate cell proliferation, growth, differentiation and motility as well as synthesis and deposition of the extracellular matrix. They are involved in various physiological processes including embryogenesis, tissue remodeling and wound healing. They are secreted predominantly as latent complexes which are stored at the cell surface and in the extracellular matrix. The release of biologically active TGF-β isoform from a latent complex involves proteolytic processing of the complex and /or induction of conformational changes by proteins such as thrombospondin-1. TGF-β2 has been shown to exert suppressive effects on IL-2 dependent T-cell growth, and may also have an autocrine function in enhancing tumor growth by suppressing immuno-surveillance of tumor development. Recombinant human TGF-β2 is a 25.0 kDa protein composed of two identical 112 amino acid polypeptide chains linked by a single disulfide bond.
* Manufactured using (BTI-Tn-5B1-4) cells under license from the Boyce Thompson Institute for Plant Research, Inc.
|
|
)
|
|
|
ABPEP-20-2
|
| Alpha Diagnostics |
|
1 |
|
|
|
|
PROTP02765-2
|
| BosterBio |
|
Regular: 10ug |
|
Description: AHSG Human Recombinant produced by transfected human cells is a single polypeptide chain containing 357 amino acids (19-367). AHSG is fused to an 8 amino acid His-tag at C-terminus & purified by proprietary chromatographic techniques.
|
|
|
|
|
PROTP09038-2
|
| BosterBio |
|
Regular: 50ug |
|
Description: Fibroblast Growth Factor-2 Human Recombinant (FGF-2) produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 154 amino acids and having a molecular mass of 17.2kDa.;The FGF-b is purified by proprietary chromatographic techniques.
|
|
|
|
|
PROTP16035-2
|
| BosterBio |
|
Regular: 20ug |
|
Description: TIMP2 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 194 amino acids and having a molecular mass of 21.8kDa.
|
|
|
|
|
PROTP20333-2
|
| BosterBio |
|
Regular: 20ug |
|
Description: TNFR2 Human produced in E.Coli is a single, non-glycosylated polypeptide chain containing 184 amino acids and having a molecular mass of 20kDa. The TNFR2 is purified by proprietary chromatographic techniques.
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
|
|
|
PROTP49763-2
|
| BosterBio |
|
Regular: 25ug |
|
Description: PLGF2 Human Recombinant (19-170 a.a.) produced in CHO is a disulfide-linked homodimeric, glycosylated, polypeptide chain containing 152 amino acids and having a molecular mass of 33kDa.;The PLGF-2 Human Recombinant protein is purified by proprietary chromatographic techniques.
|
|
|
|
|
PROTP61769-2
|
| BosterBio |
|
Regular: 5ug |
|
Description: B2M Recombinant Human produced in E.Coli is a single, non-glycosylated polypeptide chain containing 120 amino acids (1-119 a.a.) and having a molecular mass of 14 kDa. The B2M is fused to a 21 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.
|
|
|
|
|
PROTP80188-2
|
| BosterBio |
|
Regular: 10ug |
|
Description: LCN2 Human Recombinant produced in E.Coli is a homodimeric non-glycosylated polypeptide chains consisting of two 178 amino acids and having a molecular mass of 41.0kDa.
|
|
|
|
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
)
|
|
